2EURICH DT, MAJUMDAR SR, TSUYUKI RT, et al. Reduced mortality associated with the use of ACE inhibi- tors in patients with type 2 diabetes [ J ]. Diabetes Care, 2004, 27 (6) : 1330-1334.
3IMAI E, CHAN JC, ITO S, et al. Effects of olmesartan on renal and cardiovascular outcomes in type 2 diabetes with overt nephropathy: a muhicentre, randomised, pla- cebo-controlled study [J]. Diabetologia, 2011, 54 (12) : 2978-2986.
